Showing results (211-220 of 496) with videos related to

Sort By:
Pageof 50
Frontiers in Immunology|August 1, 2020
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer TreatmentStephan Klöß, Susann Dehmel, Armin Braun, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2023
Prospects for macrolide therapy of asthma and COPDMichael J Parnham, Virginia Norris, Jennifer A Kricker, et al.
International Journal of Pharmaceutics|June 27, 2020
A sensitive in vitro performance assay reveals the in vivo drug release mechanisms of long-acting medroxyprogesterone acetate microparticlesGe Fiona Gao, Manuela Thurn, Bernd Wendt, et al.
The Journal of Pain|May 9, 2012
Inhibitor kappa B kinase beta dependent cytokine upregulation in nociceptive neurons contributes to nociceptive hypersensitivity after sciatic nerve injuryMaike Kanngiesser, Annett Häussler, Thekla Myrczek, et al.
Journal of Medicinal Chemistry|March 28, 2012
Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1)Florian Rörsch, Estella Buscató, Klaus Deckmann, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2009
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MSHarald Farnik, Juliane El-Duweik, Christoph Welsch, et al.
Frontiers in Psychiatry|February 27, 2019
A Data Science-Based Analysis Points at Distinct Patterns of Lipid Mediator Plasma Concentrations in Patients With DementiaRobert Gurke, Semra Etyemez, David Prvulovic, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2013
Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesiaJörn Lötsch, Carsten Skarke, Jutta Darimont, et al.
Plos One|April 23, 2014
Consequences of a human TRPA1 genetic variant on the perception of nociceptive and olfactory stimuliMichael Schütz, Bruno G Oertel, Dirk Heimann, et al.
British Journal of Pharmacology|October 12, 2023
Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoidsTim J Schäufele, Anja Kolbinger, Joschua Friedel, et al.
Pageof 50